The Filing Desk

Innovex International

INVX · NYSE · Energy · Financials, fiscal 2016 to 2025

INVX · Last close · October 26, 2026
$30.66
Value Innovex International yourself

Innovex International's revenue rose 48.0% to $978 million in fiscal 2025. Its operating margin was 13.6%, up from 7.4% a year earlier. It paid out $9 million in dividends and buybacks. The diluted share count rose 37.0%.

INNOVEX INTERNATIONAL, INC. Latest fiscal year ended December 31, 2025 10-K filed February 24, 2026 · 0001193125-26-067228 Updated
Revenue
$978M
48.0%
Operating margin
13.6%
6.1 pts
Net income
$83M
40.6%
Free cash flow
—
 
Return on equity
8.3%
13.5 pts
Market cap
$2.1B
Oct 26 close
P/E
34.4x
On $0.89 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

Revenue and margins

Revenue
US$ billions, fiscal years
Margins
Percent of revenue
GrossOperatingNetFree cash flow

Net income and earnings per share

From fiscal 2016 to 2025, earnings per share fell 7.7% a year and net income 1.2% a year, as new shares raised the share count by 84% and diluted each share's earnings.

Net income
US$ billions, fiscal years; loss years in red.
Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Cash flow

Free cash flow
US$ billions. Cash from operations minus capital expenditure; negative years in red.

Payouts and share count

Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Valuation

Two ways to value Innovex International yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.

Discounted cash flow (DCF)

A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Innovex International's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.

Value per share on three example scenarios, from Innovex International's cash from operations minus depreciation in fiscal 2025 (free cash flow before spending to grow, as its free cash flow was not available) of $130M, net cash of $178M at December 31, 2025 and 69 million diluted shares, from its filings. The scenarios are fitted to Innovex International: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 39.3% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 13%: 11% for a cyclical or higher-risk business (Oil & Gas Equipment & Services), plus 1 point as a smaller company, worth $2.1B, plus 1 point for unsteady results (a loss in fiscal 2021); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

From the filings
Cash from operations minus depreciation in fiscal 2025: a rough guide to cash flow before spending to grow, for a company building heavily.
Cash and short-term investments minus debt and finance leases at December 31, 2025. Negative means net debt.
Weighted-average diluted shares in fiscal 2025.
Your assumptions
Start from
Fitted to Innovex International's own revenue growth, as above. Cautious: growth of 10% then 6% a year, 2% after year 10, a 14% discount rate. Base: growth of 20% then 11% a year, 2.5% after year 10, a 13% discount rate. Optimistic: growth of 25% then 14% a year, 3% after year 10, a 12% discount rate.
Long-run growth forever after year 10. Usually close to inflation, and always below the discount rate.
The yearly return an investor wants for the risk. A higher rate gives a lower value.
Value per share on these assumptions
—
—
Last close, October 26, 2026
$30.66
Value on these assumptions, against the last close
—

Cash flows in years 1 to 10, valued today
—
Everything after year 10, valued today
—
Plus net cash
—
Share of value from after year 10
—
Projected free cash flow
US$ billions. Each column is one year's projected free cash flow, split into what it is worth today and the part removed by discounting.
Value todayRemoved by discounting

How the value changes with two assumptions

Value per share in US$, with the growth rates above. The highlighted cell matches the current assumptions.
How the model works. Free cash flow grows at the first rate for five years and the second rate for five more, and each year is discounted at the discount rate. Everything after year 10 is valued as year-10 cash flow × (1 + growth after year 10) ÷ (discount rate − growth after year 10), discounted back ten years. Net cash is added and the total is divided by diluted shares. The result depends entirely on the assumptions. It is not a forecast, a price target or a recommendation. The last close is the consolidated US closing price, from Databento.

Price-to-earnings (P/E) method

Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.

Value per share on three example scenarios, from Innovex International's earnings per share of $0.89 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 34.4×, the middle of Innovex International's own P/E today, its peers' median and its sector's median (Innovex International's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 14%, 13% and 12%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

Diluted earnings per share over the four quarters to June 30, 2026, from the 10-Qs and 10-K.
P/E today is the last close divided by the latest earnings per share, the four quarters' where available. Peers: Kodiak Gas Services, Tidewater.
Starts at Innovex International's revenue growth over the last 3 years, 39.3% a year, kept between 0% and 20%, as the base scenario does.
Earnings per share in the years ahead, US$
Type your own estimate for any year; the years after it carry on at the growth rate.
Apply the multiple to earnings
A multiple on a future year's earnings gives the price then, brought back to today at the discount rate below.
The yearly return an investor wants for the risk, as in the cash flow model.
Value per share today at this multiple
—
—
Last close, October 26, 2026
$30.66
Value at this multiple, against the last close
—
Innovex International's P/E at the last close
34.4×
CompanyLast closeEarnings per shareP/E today
Kodiak Gas ServicesKGS$45.45$0.8454.1×
Innovex InternationalINVX$30.66$0.8934.4×
TidewaterTDW$84.49$4.9017.2×
How the P/E method works. Value per share is earnings per share times the multiple. On a future year's earnings, that gives the price in that year, which is brought back to today at the discount rate: price ÷ (1 + discount rate) for each year ahead. It is quick and easy to compare across companies, but it ignores debt and cash, and earnings can swing with one-off gains and charges, so a multiple says most about steady, profitable businesses. Like the cash flow model, the result depends entirely on the assumptions you choose. It is not a forecast, a price target or a recommendation.

Balance sheet

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments356292213—203
Debt incl. finance leases——503626
Net debt (negative means net cash)——−163—−178
Net debt to EBITDA——−1.4x—−0.9x
Debt to equity——0.1x0.0x0.0x
Interest coverage−159.3x18.8x17.7x20.2x51.4x
Current ratio8.0x8.6x3.7x3.9x4.9x
Quick ratio6.4x6.9x1.9x2.3x3.2x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Insider trades

Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Innovex International shares on the open market, and 4 insiders sold $308.5 million, all of it under trading plans set up in advance.

DateInsiderTradeSharesPriceValueFiling
Aug 10, 2026Jason TurowskyDirector, 10% ownerSold plan5,000,000$28.71$143.6 millionForm 4
Aug 4, 2026Mark ReddoutPresident of North AmericaSold plan10,000$30.00$300,000Form 4
Jun 2, 2026Mark ReddoutPresident of North AmericaSold plan10,750$28.00$301,000Form 4
Feb 27, 2026Interval Capital Associates II LLCDirector, 10% ownerSold plan6,612,500$24.59$162.6 millionForm 4
Feb 24, 2026Adam AndersonChief Executive Officer, DirectorSold plan18,837$28.50$536,854Form 4
Feb 23, 2026Adam AndersonChief Executive Officer, DirectorSold plan13,241$27.00$357,507Form 4
Jan 14, 2026Mark ReddoutPresident of North AmericaSold plan20,000$25.00$500,000Form 4
Jan 14, 2026Adam AndersonChief Executive Officer, DirectorSold plan13,241$25.00$331,025Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Piotroski F-score

The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassPassFail
Cash from operations exceeds net incomePassFailPass
Debt fell relative to assets—PassPass
Current ratio roseFailPassPass
Share count didn't riseFailFailFail
Gross margin rosePassPassFail
Revenue rose relative to assetsPassPassFail
F-score—7 of 95 of 9
Accruals ratio−0.3%5.6%−8.7%
The accruals ratio is net income minus cash from operations, over average total assets.

Compare

Put Innovex International side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Innovex InternationalFY2548.0%13.6%——−0.9x5
CactusFY25−4.5%23.2%—17.1%−0.3x—Compare
Atlas Energy SolutionsFY253.7%−1.0%−2.8%——4Compare
Kodiak Gas ServicesFY2512.8%26.0%21.7%6.3%4.2x5Compare
TidewaterFY250.5%20.9%26.1%19.4%0.3x7Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score above.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue539456385415365322362424661978
Revenue growth−36.2%−15.5%−15.6%7.8%−12.0%−11.7%12.2%17.2%55.8%48.0%
Gross profit2101259112095135364233303
Research and development——————2347
Operating income113−69−1233−64−125769749133
Net income93−101−962−31−128637414083
Diluted EPS (US$)2.47−2.69−2.580.05−0.87−3.632.012.292.771.20
Diluted shares (millions)38383736353531325169
Cash flow
Cash from operations2461084615−2138−67693191
Capital expenditure2628321212101933——
Free cash flow22180133−3328−2543——
Dividends paid00000000750
Share buybacks24010027252421009
Acquisitions1322000000826684
Stock-based compensation121414161315121314
Balance sheet at fiscal year end
Cash and short-term investments424493418399346356292213—203
Debt incl. finance leases———————503626
Total assets1,4611,4001,1921,2071,1511,0109704751,1981,268
Total liabilities1051059611611011398146239211
Shareholders' equity1,3561,2941,0961,0911,0421812513299581,058
Margins and ratios
Gross margin39.0%27.5%23.7%28.9%26.1%4.1%14.6%15.1%35.2%31.0%
Operating margin20.9%−15.2%−31.9%0.7%−17.4%−38.9%21.0%22.9%7.4%13.6%
Net margin17.3%−22.1%−24.9%0.4%−8.4%−39.9%17.5%17.4%21.2%8.5%
Free cash flow margin41.0%17.6%3.5%0.8%−9.1%8.8%−6.8%10.2%——
Return on capital——————————
Return on equity7.0%−7.6%−8.0%0.2%−2.9%−21.0%29.3%25.5%21.8%8.3%
Return on assets6.5%−7.0%−7.4%0.1%−2.6%−11.9%6.4%10.2%16.8%6.8%
Net debt to EBITDA———————−1.4x—−0.9x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Innovex International's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Innovex International.